Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RSBN1 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | RPS9 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | LARP6 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | EHMT1 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | WRN | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | OPTN | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | KATNA1 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | CHST3 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | TMEM147 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | CREB1 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |